• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Diagn Microbiol Infect Dis . "Enhanced seropositivity and sustained antibody response among healthcare workers: A seroprevalence study during the S

tetano

Editor, Senior Moderator
Diagn Microbiol Infect Dis


. 2025 Jul 8;113(3):116996.
doi: 10.1016/j.diagmicrobio.2025.116996. Online ahead of print. "Enhanced seropositivity and sustained antibody response among healthcare workers: A seroprevalence study during the SARS-CoV-2 pandemic

Anagoni Srikar[SUP] 1 [/SUP], Mudhigeti Nagaraja[SUP] 2 [/SUP], Alladi Mohan[SUP] 3 [/SUP], Kodavala Sireesha[SUP] 4 [/SUP], Anju Verma[SUP] 5 [/SUP], Usha Kalawat[SUP] 6 [/SUP]



Affiliations
Abstract

Background: Healthcare workers (HCWs) are a well-known risk group for coronavirus infection with increased working hours in a potentially infectious environment and immunity levels to be monitored.
Methods: 1001 HCWs were tested for both IgG and Neutralizing antibodies. IgG avidity was tested in 100 HCWs using 3 M, 5 M and 7 M urea concentration. One-year follow-up testing for both IgG and Neutralizing antibodies was performed in 151 HCWs.
Results: COVID-19 IgG antibody levels were high among 299 (94.62 %) HCWs with a history of COVID-19 infection (p <0.0001) compared to 479 (69.92 %) HCWs who were not infected with COVID-19 during the first and second waves. A total of 899 (89.81 %) HCWs had more than 50 % neutralizing antibodies, whereas the remaining 102 (10.19 %) HCWs had less than 50 % neutralizing antibodies. The avidity index was maintained at approximately 40 % (grey zone). In our study, 5.1 folds the IgG levels increased after 1 year compared to the initial results, with a 6.3 folds increase in the high-risk group compared to 3.6 folds increase in the low-risk group.
Conclusions: Healthcare workers with a higher infection rate and two-fold higher IgG levels in HCWs involved in COVID-19 duty and their persistence for a longer time than in other groups signify sustained antibody responses of IgG antibodies, which play a crucial role in reducing the severity of disease in HCWs involved in COVID-19 patient care and may provide protection against emerging SARS-CoV-2 variants.

Keywords: Antibody avidity; Healthcare workers; IgG antibody; Neutralizing antibody; SARS-CoV-2.

 
Back
Top Bottom